Phosphodiesterase Inhibitors as a Target for Cognition Enhancement in Aging and Alzheimer’s Disease: A Translational Overview

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|21|3|317-331

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.3, 2015-01, pp. : 317-331

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selective phosphodiesterase inhibitors: a promising target for cognition enhancement

By Reneerkens Olga Rutten Kris Steinbusch Harry Blokland Arjan Prickaerts Jos

Psychopharmacology, Vol. 202, Iss. 1-3, 2009-01 ,pp. : 419-443

Springer Publishing Company

Access to resources Recommend Favorite

Astroglial Connexins as a Therapeutic Target for Alzheimer's Disease

Current Pharmaceutical Design, Vol. 23, Iss. 33, 2018-01 ,pp. : 4958-4968

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacoeconomics of Cholinesterase Inhibitors in the Treatment of Alzheimers Disease

By Jönsson L.

PharmacoEconomics, Vol. 21, Iss. 14, 2003-01 ,pp. : 1025-1037

Adis International

Access to resources Recommend Favorite

Acetylcholinesterase inhibitors in the treatment of Alzheimer’s disease

By Gauthier S.

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 10, 1999-10 ,pp. : 1511-1520

Informa Healthcare

Access to resources Recommend Favorite

Phosphodiesterase Inhibitors for Cognitive Enhancement

Current Pharmaceutical Design, Vol. 11, Iss. 26, 2005-10 ,pp. : 3329-3334

Bentham Science Publishers

Access to resources Recommend Favorite